Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Laura Orsolini, Fabiola Sarchione, Federica Vellante, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 5, pp. 583-606
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians
Dimitra S. Mouliou
Diseases (2023) Vol. 11, Iss. 4, pp. 132-132
Open Access | Times Cited: 42
Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
Theoharis C. Theoharides, Irene Tsilioni, Mona Abubakr Bawazeer
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 122
Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
Rune A. Kroken, Iris E. Sommer, Vidar M. Steen, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 76
Sex differences in the blood–brain barrier: Implications for mental health
Laurence Dion‐Albert, Luisa Bandeira Binder, Béatrice Daigle, et al.
Frontiers in Neuroendocrinology (2022) Vol. 65, pp. 100989-100989
Open Access | Times Cited: 63
The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
Manuel Morrens, C. Overloop, Violette Coppens, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3237-3246
Open Access | Times Cited: 52
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 34
Effect of Probiotics on C-Reactive Protein Levels in Schizophrenia: Evidence from a Systematic Review and Meta-Analysis
Verónica Romero‐Ferreiro, Lorena García‐Fernández, José Miguel Biscaia Fernández, et al.
Complementary Therapies in Medicine (2025), pp. 103126-103126
Open Access | Times Cited: 1
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 457-457
Open Access | Times Cited: 69
Increased C‐reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta‐analysis
Alessandro Miola, Veronica Dal Porto, Tal Tadmor, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 6, pp. 537-552
Open Access | Times Cited: 50
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis
Valentine Lestra, Bruno Roméo, Catherine Martelli, et al.
Schizophrenia Research (2022) Vol. 246, pp. 175-186
Open Access | Times Cited: 30
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
Altijana Hromić‐Jahjefendić, Debmalya Barh, Vladimir N. Uversky, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 208-208
Open Access | Times Cited: 18
Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders
Wolfgang Jordan, Henrik Dobrowolny, Sabine Bahn, et al.
European Archives of Psychiatry and Clinical Neuroscience (2016) Vol. 268, Iss. 2, pp. 129-143
Closed Access | Times Cited: 52
Oleanolic Acid Exerts a Neuroprotective Effect Against Microglial Cell Activation by Modulating Cytokine Release and Antioxidant Defense Systems
José M. Castellano, Silvia Garcia-Rodriguez, Juan Manuel Espinosa, et al.
Biomolecules (2019) Vol. 9, Iss. 11, pp. 683-683
Open Access | Times Cited: 49
Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
Maria Antonietta Nettis, Giulio Pergola, Anna Kolliakou, et al.
Psychoneuroendocrinology (2018) Vol. 99, pp. 145-153
Open Access | Times Cited: 48
Inflammatory Biomarkers in Addictive Disorders
Álvaro Morcuende, Francisco Navarrete, Elena Nieto, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 33
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, et al.
General Psychiatry (2022) Vol. 35, Iss. 1, pp. e100685-e100685
Open Access | Times Cited: 25
Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study
Bochao Lin, Anne Alkema, Triinu Peters, et al.
International Journal of Epidemiology (2019) Vol. 48, Iss. 5, pp. 1505-1514
Open Access | Times Cited: 38
Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies
Emanuele F. Osimo, Luke Baxter, Jan Štochl, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases
Yuke Tian, Dawei Ye, Meng-Meng Ge, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2066-2080
Open Access | Times Cited: 21
Is there an association between inflammatory/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample
Alice Caldiroli, Enrico Capuzzi, Jennifer L. Barkin, et al.
Brain Behavior & Immunity - Health (2022) Vol. 22, pp. 100453-100453
Open Access | Times Cited: 19
Correlation of allostatic load and perceived stress with clinical features in first-episode schizophrenia
Yanfang Zhou, Leilei Wang, Kebing Yang, et al.
Journal of Psychiatric Research (2024) Vol. 172, pp. 156-163
Closed Access | Times Cited: 4
Circulating Blood-Based Proteins in Psychopathology and Cognition
Upasana Bhattacharyya, Jibin John, Max Lam, et al.
JAMA Psychiatry (2025)
Closed Access
Relationships Between Immune‐Inflammatory Features and Social Cognitive Impairments in Patients With Schizophrenia Spectrum Disorders: A Systematic Review
Alexandre Carpentier, D. Zampetas, A. Durand, et al.
Brain and Behavior (2025) Vol. 15, Iss. 4
Open Access
The Effects of Exercise on IL-6 Levels and Cognitive Performance in Patients with Schizophrenia
Pablo Gómez-Rubio, Isabel Trapero
Diseases (2019) Vol. 7, Iss. 1, pp. 11-11
Open Access | Times Cited: 34
The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis
I‐Chen Tsai, Chih‐Wei Hsu, Chun-Hung Chang, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1235-1235
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top